Humira®/Biosimilars Forecast for 2023 and Beyond
The biosimilars for the blockbuster drug Humira® will hit the market in 2023. Join our team as we discuss the complexities surrounding biosimilars, how they may influence the pharmacy landscape and the important considerations employers should know. We look forward to having you attend the event! Presented by: Andrea Grance, R.Ph. Principal, Brown & Brown […]
